Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2026 is -16.95% vs -0.90% in Mar 2025
Other Long Term Liabilities
YoY Growth in year ended Mar 2026 is 18.18% vs 11.39% in Mar 2025
Fixed Assets
YoY Growth in year ended Mar 2026 is -6.23% vs -15.00% in Mar 2025
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2026 is 11.99% vs 19.28% in Mar 2025
Compare Balance Sheet Results of Goldline Pharmac
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
8.71
185.90
-177.19
-95.31%
Share Warrants & Outstandings
Total Reserve
5.54
22.57
-17.03
-75.45%
Shareholder's Funds
14.25
208.46
-194.21
-93.16%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
3.21
0.00
3.21
0.00%
Secured Loans
0.66
0.00
0.66
0.00%
Unsecured Loans
2.55
0.00
2.55
0.00%
Deferred Tax Assets / Liabilities
-0.08
0.00
-0.08
0.00%
Other Long Term Liabilities
1.04
0.00
1.04
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.00
0.00
0.00%
Total Non-Current Liabilities
2.43
212.75
-210.32
-98.86%
Current Liabilities
Trade Payables
1.85
195.02
-193.17
-99.05%
Other Current Liabilities
2.56
35.72
-33.16
-92.83%
Short Term Borrowings
7.70
0.00
7.70
0.00%
Short Term Provisions
0.00
0.00
0.00
0.00%
Total Current Liabilities
12.11
230.74
-218.63
-94.75%
Total Liabilities
28.79
651.96
-623.17
-95.58%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
3.76
0.01
3.75
37,500.00%
Less: Accumulated Depreciation
1.06
0.00
1.06
0.00%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
2.71
0.00
2.71
0.00%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.03
0.00
0.03
0.00%
Long Term Loans & Advances
0.02
0.00
0.02
0.00%
Other Non Current Assets
0.00
0.00
0.00
0.00%
Total Non-Current Assets
2.75
0.00
2.75
0.00%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
6.21
1.58
4.63
293.04%
Sundry Debtors
16.13
252.19
-236.06
-93.60%
Cash and Bank
0.59
46.57
-45.98
-98.73%
Other Current Assets
1.13
0.00
1.13
0.00%
Short Term Loans and Advances
1.98
351.61
-349.63
-99.44%
Total Current Assets
26.05
651.96
-625.91
-96.00%
Net Current Assets (Including Current Investments)
13.93
421.21
-407.28
-96.69%
Total Current Assets Excluding Current Investments
26.05
651.96
-625.91
-96.00%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
28.79
651.96
-623.17
-95.58%
Contingent Liabilities
3.37
0.00
3.37
0.00%
Total Debt
7.41
212.75
-205.34
-96.52%
Book Value per share (adjusted)
18.03
1.02
17.01
1,667.65%
Annual - Borrowings
Borrowings 9.16 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -16.95% vs -0.90% in Mar 2025
Annual - Other Long Term Liabilities
Other Long Term Liabilities 1.04 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 18.18% vs 11.39% in Mar 2025
Annual - Fixed Assets
Fixed Assets 2.71 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -6.23% vs -15.00% in Mar 2025
Annual - Investments
Investments 0.03 Cr
in Mar 2026Figures in Cr
No Investments in the last few periods;
Annual - Current Assets
Current Assets 26.05 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 11.99% vs 19.28% in Mar 2025






